Medpace Holdings (MEDP) Share-based Compensation Growth (1y) (2016 - 2026)
Medpace Holdings (MEDP) Share-based Compensation Growth (1y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.44 Bn | 209.37 Bn | 8.34 Bn | 1.23% |
| 2 | Danaher | 139.95 Bn | 135.60 Bn | 3.61 Bn | 2.20% |
| 3 | Idexx Laboratories | 46.16 Bn | 45.96 Bn | 779.09 Mn | 8.31% |
| 4 | Agilent Technologies | 39.67 Bn | 37.87 Bn | 990.00 Mn | 0.00% |
| 5 | Iqvia Holdings | 39.29 Bn | 37.21 Bn | 1.44 Bn | 58.33% |
| 6 | Natera | 38.61 Bn | 37.51 Bn | 696.04 Mn | - |
| 7 | Illumina | 29.99 Bn | 28.82 Bn | 770.00 Mn | 5.80% |
| 8 | Mettler Toledo International | 28.57 Bn | 28.51 Bn | 650.22 Mn | -0.20% |
| 9 | Quest Diagnostics | 26.17 Bn | 25.55 Bn | 1.03 Bn | 500.00% |
| 10 | Medpace Holdings | 16.56 Bn | 16.06 Bn | 201.64 Mn | -26.94% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -26.94% |
| Mar 31, 2026 | -70.89% |
| Dec 31, 2025 | -4.57% |
| Sep 30, 2025 | -46.08% |
| Jun 30, 2025 | 65.86% |
| Mar 31, 2025 | 291.93% |
| Dec 31, 2024 | 14.02% |
| Sep 30, 2024 | 134.21% |
| Jun 30, 2024 | -26.87% |
| Mar 31, 2024 | -20.74% |
| Dec 31, 2023 | -7.65% |
| Sep 30, 2023 | -13.58% |
| Jun 30, 2023 | -13.21% |
| Mar 31, 2023 | 24.38% |
| Dec 31, 2022 | 40.49% |
| Sep 30, 2022 | 43.17% |
| Jun 30, 2022 | 58.35% |
| Mar 31, 2022 | 52.28% |
| Dec 31, 2021 | 34.45% |
| Sep 30, 2021 | 46.52% |